Blood test may spare some lung cancer patients from chemo

NCT ID NCT05715229

Recruiting now Disease control Sponsor: Hackensack Meridian Health Source: ClinicalTrials.gov ↗

First seen Jan 22, 2026 · Last updated Jun 11, 2026 · Updated 21 times

Summary

This study looks at whether a simple blood test that tracks tumor DNA can help doctors decide if patients with advanced lung cancer can be treated with immunotherapy alone or need chemotherapy added. About 108 adults with newly diagnosed stage IV non-small cell lung cancer will participate. The goal is to see if using the blood test leads to better control of the cancer compared to standard treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Jersey Shore University Medical Center
NOT_YET_RECRUITING

Neptune City, New Jersey, 07753, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Email: •••••@•••••
John Theurer Cancer Center, Hackensack Meridian Health
RECRUITING

Hackensack, New Jersey, 07410, United States

Contact Phone: •••-•••-••••
Lombardi Comprehensive Cancer Center, Georgetown University
NOT_YET_RECRUITING

Washington D.C., District of Columbia, 20007, United States

Conditions

Explore the condition pages connected to this study.

CARCINOMA, NON-SMALL-CELL LUNG